Results 171 to 180 of about 16,531 (215)

Dupilumab as a novel steroid-sparing treatment for pemphigoid gestationis: A new case report and review of literature. [PDF]

JAAD Case Rep
Phong CH, Lee BA, Grando SA.
europepmc   +1 more source

Azacitidine-induced bullous pemphigoid-like localized toxic reaction. [PDF]

Einstein (Sao Paulo)
Nogueira RBE, Tatsui NH, Almeida LR, Pincelli MS, Maruta CW, Sanches JA, Velloso EDRP, Nukui Y.   +7 more
europepmc   +1 more source

Bullous eruption on the posterior thigh [PDF]

, 2005
Stonehouse, Amber, Studdiford, James
core   +1 more source

Home-based collaborative management of bullous pemphigoid with delayed seropositive conversion of anti-BP180-NC16a antibody. [PDF]

J Gen Fam Med
Yamashita H, Ando T, Fujikawa H, Shiota M.   +3 more
europepmc   +1 more source

Efficacy and safety of dupilumab in patients with moderate-to-severe bullous pemphigoid: a systematic review and meta-analysis. [PDF]

An Bras Dermatol
da Silva JON, E Silva RR, Zattar Ribeiro PV, Farah PS, Steglich RB.   +4 more
europepmc   +1 more source

Outcomes and risk factors of COVID-19 in patients with bullous pemphigoid: a cross-sectional study. [PDF]

Front Immunol
Zhang Y, Huang D, Shi Y, Ding Y, Gao Y.
europepmc   +1 more source

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum. [PDF]

JAAD Case Rep
Kotnik N, Diercks GFH, Jalving H, Hospers GAP, Oosting SF, van Kruchten M, Hiltermann TJN, Bolling MC, Bremer J, Horváth B, Meijer JM.   +10 more
europepmc   +1 more source

Talimogene laherparepvec induced bullous pemphigoid. [PDF]

JAAD Case Rep
Davoudi S, Mahmoud F, Abbott J.
europepmc   +1 more source

An Adverse Double-Hit by Pembrolizumab: A Case Report of Bullous Pemphigoid and Pneumonitis. [PDF]

J Med Cases
Chatzigrigoriadis C, Avramidis P, Davoulos C, Dimitrakopoulos FI, Eleftherakis G, Petropoulou C, Sperdouli D, Stergiopoulos GM, Galiatsatos P, Assimakopoulos S.   +9 more
europepmc   +1 more source